Literature DB >> 18518731

Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma.

Ritesh Banerjee1, James P Moriarty, Robert L Foote, Bruce E Pollock.   

Abstract

OBJECT: The best approach to the management of vestibular schwannoma (VS) remains controversial. The aim of this study is to analyze the initial and follow-up costs of resection and stereotactic radiosurgery for patients with VS.
METHODS: Initial and follow-up costs in 53 cases in which patients with unilateral, previously unoperated VSs > 3 cm underwent resection (21 cases) or radiosurgery (32 cases) at the Mayo Clinic from June 2000 until July 2002 were analyzed for 36 months. Follow-up treatment-specific utilization records were gathered prospectively for patients not returning to the Mayo Clinic after treatment. Six-month moving averages of incremental follow-up costs were calculated for the 2 patient groups.
RESULTS: The mean cost of surgery in the microsurgery group was $23,788 (95% confidence interval $22,280-$24,842) compared with $16,143 (95% confidence interval $15,277-$17,545) for the radiosurgical group. Mean incremental follow-up costs per month for patients in the microsurgery group started just > $1,000 per month, decreased steadily, and remained < $70 per month by the 10th month of follow-up. Mean incremental follow-up costs per month for patients in the radiosurgery group were <$10 per month for the first few months and thereafter increased to as much as $200 per month.
CONCLUSIONS: Although the total cost of microsurgery is higher due to the costs of hospitalization, follow-up costs for radiosurgery are greater in general. From a societal perspective, radiosurgery is less expensive than microsurgical resection provided that the rate of tumor progression after radiosurgery remains low with long-term follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18518731     DOI: 10.3171/JNS/2008/108/6/1220

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Health Care Utilization in Patients Undergoing Repeat Stereotactic Radiosurgery for Vestibular Schwannoma with 5-Year Follow-up: A National Database Analysis.

Authors:  Nicholas Dietz; Mayur Sharma; Beatrice Ugiliweneza; Dengzhi Wang; Maxwell Boakye; Brian Williams; Norberto Andaluz
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-10

2.  Endoscopic-Assisted Keyhole Middle Cranial Fossa Approach for Small Vestibular Schwannomas.

Authors:  In Seok Moon; Ick Soo Choi; Seung Ho Shin; Seungjoon Yang; Youngrak Jung; Gina Na
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

3.  A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients.

Authors:  Siok Swan Tan; Erik van Putten; Wideke M Nijdam; Patrick Hanssens; Guus N Beute; Peter J Nowak; Clemens M Dirven; Leona Hakkaart-van Roijen
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.130

4.  Role of stereotactic radiosurgery in meningiomas and vestibular schwannomas.

Authors:  Jeffrey T Jacob; Michael J Link; Bruce E Pollock
Journal:  Curr Treat Options Neurol       Date:  2014-08       Impact factor: 3.598

5.  Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.

Authors:  Bethany M Anderson; Deepak Khuntia; Søren M Bentzen; Heather M Geye; Lori L Hayes; John S Kuo; Mustafa K Baskaya; Behnam Badie; Amar Basavatia; G Mark Pyle; Wolfgang A Tomé; Minesh P Mehta
Journal:  J Neurooncol       Date:  2013-10-20       Impact factor: 4.130

6.  Stereotactic radiosurgery and stereotactic body radiation therapy cost-effectiveness results.

Authors:  Akash Bijlani; Giovanni Aguzzi; David W Schaal; Pantaleo Romanelli
Journal:  Front Oncol       Date:  2013-04-08       Impact factor: 6.244

Review 7.  Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs.

Authors:  Nikhilesh Bhatt; Mintu Turakhia; Thomas J Fogarty
Journal:  Cureus       Date:  2016-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.